Company Overview and News

 
UPDATE 1-UK Stocks-Factors to watch on Aug 23

2018-08-23 reuters
Aug 23 (Reuters) - Britain’s FTSE 100 index is seen opening 18 points lower at 7,557 on Thursday, according to financial bookmakers, with futures down 0.2 percent ahead of the cash market open.
CCV CCZ ITYBF 50GP CUKPF PUK CCL OSB COIHD LSE COIHF PHXXY PMOIY CMCSK PUKPF IMBBY CMCSA PMOIF CCL PHXXF CUK PMO 49GP CCV.CL COIHY CRDA IMBBF

 
Aviva On Track And Undervalued

2018-08-22 seekingalpha
Aviva's first half operating profits were a little better than expected, even after one-time items, as the U.K. life business grew nicely.
PUK PUKPF

 
Prudential PLC (PUK) CEO Mike Wells on Q2 2018 Results - Earnings Call Transcript

2018-08-13 seekingalpha
So, I want to walk you through what we think are a strong set of numbers, update you on the demerger, a variety of other topics. And I’d say we won’t talk about Tesla. How’s that? Is that the only guarantee today? The headline numbers, let’s go through them. So in context, what we’ve been trying to do, as we’ve talked in the last few years, is the definition of quality earning being earnings that are recurring, client relationships that carry over year-after-year, that, the development of our existing consumer relationships that give us a resilience across the cycle.
DB PUK MS PUKPF

94
NXGEF / Nexgen Energy Ltd. - Stock Institutional Ownership and Shareholders - Fintel.io

2018-08-10 fintel.io - 1
Nexgen Energy Ltd. (OTC:NXGEF) has 52 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 54,727,711 shares. Largest shareholders include Global X Management CO LLC, Russell Investments Group, Ltd., 1832 Asset Management L.P., Henderson Group Plc, Morgan Stanley, Tanaka Capital Management Inc, Bienville Capital Management, LLC, Cambrian Capital Limited Partnership, Prudential Plc, and Public Sector Pension Investment Board.
NYMX NXGEF IVN SU TWMJF THO NXE PUK WEED MS PUKPF CBWBF SU TAHO BIR BIREF HGG CGC IVPAF JHG BTE

3
Ping An Insurance Group considers buying Prudential’s Asian business

2018-08-09 livemint
Hong Kong/London/Beijing: Ping An Insurance (Group) Co. is considering buying Prudential Plc’s Asia business, people familiar with the matter said, a deal that would reshape Asia’s booming insurance industry and mark the biggest-ever Chinese acquisition.
BRK.A PUK PUKPF

5
Deals of the day-Mergers and acquisitions

2018-08-08 reuters
Aug 8 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1500 GMT on Wednesday:
FOX BPKD HKBNY ALORY SMGKF IX STWD.WI HKBNF SMIN SMGZY PUK ICUI STWD FOXA 85PL PUKPF AVOL

 
Prudential Asia profit rose as Ping An said to mull bid for unit

2018-08-08 theedgemarkets
(Aug 8): Prudential Plc’s focus on Asia is paying off and its business in the region is drawing interest from competitors.
MTSI PUK PUKPF

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to PUK / Prudential PLC on message board site Silicon Investor.

frenchmen i admire the most frenchmen i admire the most frenchmen i admire the most
CUSIP: 74435K204